Conviction
$ Value
$1.0M
Shares
125,000
Price
$8
Filed
Mar 11
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
MEHRA SANJEEV K
Title
—
CIK
0001029623
Roles
Transaction Details
Transaction Date
2026-03-10
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
475,000
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $7.98 to $8.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. | The Reporting Person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
Filing Info
MEHRA SANJEEV K's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | AVTR | ▲ | $1.0M |
| 2025-12-05 | AVTR | A | $0 |
| 2025-12-05 | AVTR | ▲ | $3.9M ★ |
Other Insiders at AVTR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SUMME GREGORY L | $940K | — | 2026-02-12 |
| LUCIER GREGORY T | $458K | — | 2026-02-19 |
|
Jones R. Brent
EVP, Chief Financial Officer
|
— | — | 2026-02-23 |
|
Eck Steven W
SVP & Chief Accounting Officer
|
— | — | 2026-04-03 |
|
Walker Corey
President, VWR Dist. & Servs.
|
— | — | 2026-02-20 |
|
Sokenu Claudius
EVP, Chief Legal & Compliance
|
— | — | 2026-02-23 |
|
Hankamer Brittany
EVP, Chief HR Officer
|
— | — | 2026-02-24 |
|
Gourdier Benoit
EVP, Bioscience & Medtech
|
— | — | 2026-02-23 |
|
Ligner Emmanuel
President and CEO
|
— | — | 2026-02-19 |
|
Blenn Mary
EVP, Chief Operating Officer
|
— | — | 2026-02-19 |